Vascular endothelial growth factor and microvessel density in periodontitis patients with and without diabetes

Journal of Periodontology

Volumn 80, Issue 11, 2009, Pages 1783-1789

  Aspriello, Simone Domenico ^a   Zizzi, Antonio ^a   Lucarini, Guendalina ^a   Rubini, Corrado ^a   Faloia, Emanuela ^a   Boscaro, Marco ^a   Tirabassi, Giacomo ^a   Piemontese, Matteo ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

Chronic periodontitis; Diabetes mellitus; Immunohistochemistry; Inflammation; Pathologic neovascularization; Vascular endothelial growth factor

Indexed keywords

CD34 ANTIGEN; VASCULOTROPIN A;

AGED; ALVEOLAR BONE LOSS; ARTICLE; CELL COUNT; CHRONIC PERIODONTITIS; COMPARATIVE STUDY; DIABETES MELLITUS; ENDOTHELIUM CELL; EPITHELIUM CELL; FEMALE; GINGIVA; GINGIVA BLEEDING; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MICROVASCULATURE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOLOGY; PERIODONTAL DISEASE; PERIODONTAL POCKET; PERIODONTICS; TOOTH PLAQUE; VASCULAR ENDOTHELIUM; VASCULARIZATION;

AGED; ALVEOLAR BONE LOSS; ANTIGENS, CD34; CELL COUNT; CHRONIC PERIODONTITIS; DENTAL PLAQUE INDEX; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; EPITHELIAL CELLS; FEMALE; GINGIVA; GINGIVAL HEMORRHAGE; HUMANS; MALE; MICROVESSELS; MIDDLE AGED; PERIODONTAL ATTACHMENT LOSS; PERIODONTAL INDEX; PERIODONTAL POCKET; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 72349092328     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2009.090239     Document Type: Article

References (35)

1. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2006;29:S43-S48.
2. Ray KK, Seshasai SR, Wijesuriya S, et al. Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: A meta-analysis of randomised controlled trials. Lancet 2009;373:1765-1772.
3. Nathan DM, Cleary PA, Backlund JY, et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005;353:2643-2653.
4. Graves DT, Liu R, Alikhani M, Al-Mashat H, Trackman PC. Diabetes-enhanced inflammation and apoptosis - Impact on periodontal pathology. J Dent Res 2006;85:15-21.
5. Pontes Andersen CC, Flyvbjerg A, Buschard K, Holmstrup P. Relationship between periodontitis and diabetes: Lessons from rodent studies. J Periodontol 2007;78:1264-1275.
6. Hernàndez C, Burgos R, Cantòn A, Garc̀ia-Arum̀i J, Segura RM, Simò R. Vitreous levels of vascular cell adhesion molecule and vascular endothelial growth factor in patients with proliferative diabetic retinopa-thy: A case-control study. Diabetes Care 2001;24:516-521.
7. Johnson RB, Serio FG, Dai X. Vascular endothelial growth factors and progression of periodontal diseases. J Periodontol 1999;70:848-852.
8. Unlü F, Gun̈eri PG, Hekimgil M, Yesxilbek B, Boyacioǧlu H. Expression of vascular endothelial growth factor in human periodontal tissues: Comparison of healthy and diabetic patients. J Periodontol 2003;74:181-187.
9. Sakallioǧlu EE, Aliyev E, Luẗfioǧlu M, Yavuz U, Acxikgoz̈ G. Vascular endothelial growth factor (VEGF) levels of gingiva and gingival crevicular fluid in diabetic and systemically healthy periodontitis patients. Clin Oral Investig 2007;11:115-120.
10. Aiello LP, Wong JS. Role of vascular endothelial growth factor in diabetic vascular complications. Kidney Int Suppl 2000;77:S113-S119.
11. Izzedine H, Bahleda R, Khayat D, et al. Electrolyte disorders related to EGFR-targeting drugs. Crit Rev Oncol Hematol 2009 Apr 27. [Epub ahead of print].
12. Pinchback JS, Taylor BA, Gibbins JR, Hunter N. Microvascular angiopathy in advanced periodontal disease. J Pathol 1996;179:204-209.
13. Minardi D, Lucarini G, Filosa A, et al. Prognostic role of tumor necrosis, microvessel density, vascular endothelial growth factor and hypoxia inducible factor-1alpha in patients with clear cell renal carcinoma after radical nephrectomy in a long term follow-up. Int J Immunopathol Pharmacol 2008;21:447-455.
14. Fina L, Molgaard HV, Robertson D, et al. Expression of the CD34 gene in vascular endothelial cells. Blood 1990;75:2417-2426.
15. Gun̈eri P, Unlü F, Yesxilbek B, et al. Vascular endothe-lial growth factor in gingival tissues and crevicular fluids of diabetic and healthy periodontal patients. J Periodontol 2004;75:91-97.
16. Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol 1999;4:1-6.
17. Lindhe J, Ranney R, Lamster I, et al. Consensus report: Chronic periodontitis. Ann Periodontol 1999;4:38.
18. Bry L, Chen PC, Sacks DB. Effects of haemoglobin variants and chemically modified derivatives on assays for glycohemoglobin. Clin Chem 2001;47:153-163.
19. Loë H. The gingival index, the plaque index and the retention index systems. J Periodontol 1967;38(Suppl.):610-616.
20. Muḧlemann HR, Son S. Gingival sulcus bleeding - A leading symptom in initial gingivitis. Helv Odontol Acta 1971;15:107-113.
21. Clarke GM, Higgins TN. Investigation of hemoglobin-opathies and thalassemias; review and update. Clin Chem 2000;46:1284-1290.
22. Salvi GE, Carollo-Bittel B, Lang NP. Effects of diabetes mellitus on periodontal and peri-implant conditions: Update on associations and risks. J Clin Periodontol 2008;35:398-409.
23. Mealey BL, Oates TW. Diabetes mellitus and periodontal diseases. J Periodontol 2006;77:1289-1303.
24. Suthin K, Matsushita K, Machigashira M, et al. Enhanced expression of vascular endothelial growth factor by periodontal pathogens in gingival fibroblasts. J Periodontal Res 2003;38:90-96.
25. Booth V, Young S, Cruchley A, Taichman NS, Paleolog E. Vascular endothelial growth factor in human periodontal disease. J Periodontal Res 1998;33:491-499.
26. Chu SC, Tsai CHT, Yang S-FY, et al. Induction of vascular endothelial growth factor gene expression by proinflammatory cytokines in human pulp and gingi-val fibroblasts. J Endod 2004;30:704-707.
27. Simonetti O, Lucarini G, Goteri G, et al. VEGF is likely a key factor in the link between inflammation and angiogenesis in psoriasis: Results of an immunohisto-chemical study. Int J Immunopathol Pharmacol 2006;19:751-760.
28. Xia YP, Li B, Hylton D, Detmar M, Yancopoulos GD, Rudge JS. Transgenic delivery of VEGF to mouse skin leads to an inflammatory condition resembling human psoriasis. Blood 2003;102:161-168.
29. Serné EH, Gans RO, ter Maaten JC, Tangelder GJ, Donker AJ, Stehouwer CD. Impaired skin capillary recruitment in essential hypertension is caused by both functional and structural capillary rarefaction. Hypertension 2001;38:238-242.
30. Serné EH, Gans RO, ter Maaten JC, ter Wee PM, Donker AJ, Stehouwer CD. Capillary recruitment is impaired in essential hypertension and relates to insulin's metabolic and vascular actions. Cardiovasc Res 2001;49:161-168.
31. Serné EH, Stehouwer CD, ter Maaten JC, et al. Microvascular function relates to insulin sensitivity and blood pressure in normal subjects. Circulation 1999;99:896-902.
32. Schulman IH, Zhous MS. Vascular insulin resistance: A potential link between cardiovascular and metabolic diseases. Curr Hypertens Rep 2009;11:48-55.
33. Kawashima S. The two faces of endothelial nitric oxide synthase in the pathophysiology of atherosclerosis. Endothelium 2004;11:99-107. (Pubitemid 39207183)
34. Bhandari V, Choo-Wing R, Chapoval SP, et al. Essential role of nitric oxide in VEGF-induced, asthma-like angiogenic, inflammatory, mucus, and physiologic responses in the lung. Proc Natl Acad Sci USA 2006;103:11021-11026.
35. Bhandari V, Choo-Wing R, Lee CG, et al. Developmental regulation of NO-mediated VEGF-induced effects in the lung. Am J Respir Cell Mol Biol 2008;39:420-430.